<DOC>
	<DOCNO>NCT02275260</DOCNO>
	<brief_summary>The REDUCE-TE Pilot study international , multicenter , prospective , single arm study compare AlCath Flux eXtra Gold ablation catheter regard prevention new subclinical cerebral thromboembolic lesion Pulmonary Vein Isolation historical data literature .</brief_summary>
	<brief_title>Reduction AF Ablation Induced Thrombo-Embolic Incidence Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Electrocardiographically document , symptomatic paroxysmal AF . Patients indication leave atrial ablation AF accord ESC guideline management atrial fibrillation . Anticoagulation accord clinical routine use coumarin derivates target INR 2.0 3.0 least 3 week prior schedule ablation procedure novel oral anticoagulant ( NOACs ) . Geographically stable duration study . Willingness ability perform write informed consent Long standing persistent persistent AF CHA2DS2VASc score â‰¥ 5 Prior ischemic stroke Transient Ischemic Attack Previous Pulmonary Vein ablation Contraindication anticoagulation therapy Contraindication DiffusionWeighted MRI Claustrophobia Contraindication transesophageal echocardiography ( TEE ) intracardiac echocardiography ( ICE , TEE possible ) Implanted cardiovascular device , include limited atrial ventricular pacemaker defibrillator lead , artificial valve , stent , septal LAA occluders Acute coronary syndrome &lt; 3 month prior schedule ablation Moderate severe valvular heart disease LA size &gt; 55 mm ( confirm echo maximum 3 month old ) Patients noncontrolled heart failure patient current recent ( &lt; 1 month prior ablation ) heart failure Ejection fraction &lt; 35 % ( confirm echo maximum 3 month old ) Conditions prevent patient 's participation neurocognitive assessment ( physician 's discretion ) Female patient pregnant breast feed plan pregnancy course study Any limitation contractual capability Simultaneous participation another study Age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>